These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19897578)

  • 1. Combination immunosuppressant therapy for patients with chronic refractory immune thrombocytopenic purpura.
    Arnold DM; Nazi I; Santos A; Chan H; Heddle NM; Warkentin TE; Kelton JG
    Blood; 2010 Jan; 115(1):29-31. PubMed ID: 19897578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura.
    Ay Y; Karapinar TH; Oymak Y; Toret E; Demirag B; Ince D; Ozcan E; Moueminoglou N; Koker SA; Vergin C
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):431-5. PubMed ID: 26656905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycophenolate mophetil therapy for chronic immune thrombocytopenic purpura resistant to steroids, immunosuppressants, and/or splenectomy in adults.
    Colović M; Suvajdzic N; Colović N; Tomin D; Vidović A; Palibrk V
    Platelets; 2011; 22(2):153-6. PubMed ID: 21142405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of idiopathic thrombocytopenic purpura (ITP) in patients with refractoriness to or with contraindication for corticosteroids and/or splenectomy with immunosuppressive therapy and danazol.
    Schiavotto C; Castaman G; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):29-34. PubMed ID: 8039755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
    Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
    Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of mycophenolate mofetil as single-agent therapy for refractory immune thrombocytopenic purpura.
    Provan D; Moss AJ; Newland AC; Bussel JB
    Am J Hematol; 2006 Jan; 81(1):19-25. PubMed ID: 16369979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate mofetil therapy for severe immune thrombocytopenia.
    Taylor A; Neave L; Solanki S; Westwood JP; Terrinonive I; McGuckin S; Kothari J; Cooper N; Stasi R; Scully M
    Br J Haematol; 2015 Nov; 171(4):625-30. PubMed ID: 26250874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolate mofetil as a treatment for refractory idiopathic thrombocytopenic purpura.
    Zhang WG; Ji L; Cao XM; Chen YX; He AL; Liu J; Zhao WH; Zou SP
    Acta Pharmacol Sin; 2005 May; 26(5):598-602. PubMed ID: 15842780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab therapy for chronic and refractory immune thrombocytopenic purpura: a long-term follow-up analysis.
    Garcia-Chavez J; Majluf-Cruz A; Montiel-Cervantes L; Esparza MG; Vela-Ojeda J;
    Ann Hematol; 2007 Dec; 86(12):871-7. PubMed ID: 17874322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is splenectomy necessary for immune thrombocytopenic purpura? The role of rituximab in patients with corticosteroid resistance in a single-center experience.
    Zhang C; Liu HF; Chen XH; Gao L; Gao L; Liu Y; Kong PY; Sun AH; Zhang X
    Clin Ther; 2014 Mar; 36(3):385-8. PubMed ID: 24594069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment options for chronic refractory idiopathic thrombocytopenic purpura in adults: focus on romiplostim and eltrombopag.
    Chouhan JD; Herrington JD
    Pharmacotherapy; 2010 Jul; 30(7):666-83. PubMed ID: 20575632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Efficacy of Azathioprine as a Second Line Therapy for Primary Immune Thrombocytopenic Purpura.
    Poudyal BS; Sapkota B; Shrestha GS; Thapalia S; Gyawali B; Tuladhar S
    JNMA J Nepal Med Assoc; 2016; 55(203):16-21. PubMed ID: 27935917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy for refractory idiopathic thrombocytopenic purpura in adolescents.
    Williams JA; Boxer LA
    J Pediatr Hematol Oncol; 2003 Mar; 25(3):232-5. PubMed ID: 12621242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporin A for the treatment of patients with chronic idiopathic thrombocytopenic purpura refractory to corticosteroids or splenectomy.
    Kappers-Klunne MC; van't Veer MB
    Br J Haematol; 2001 Jul; 114(1):121-5. PubMed ID: 11472356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A clinical study of 103 idiopathic thrombocytopenic purpura].
    Fan Y; Chang NB; Xing BL; Li YM; Pei L; Li JT
    Zhonghua Nei Ke Za Zhi; 2008 Apr; 47(4):313-5. PubMed ID: 18843957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycophenolate mofetil (MMF) for the treatment of steroid-resistant idiopathic thrombocytopenic purpura.
    Hou M; Peng J; Shi Y; Zhang C; Qin P; Zhao C; Ji X; Wang X; Zhang M
    Eur J Haematol; 2003 Jun; 70(6):353-7. PubMed ID: 12756016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractory idiopathic immune thrombocytopenic purpura in children: current and future treatment options.
    Imbach P
    Paediatr Drugs; 2003; 5(12):795-801. PubMed ID: 14658921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiagent induction and maintenance therapy for patients with refractory immune thrombocytopenic purpura (ITP).
    Boruchov DM; Gururangan S; Driscoll MC; Bussel JB
    Blood; 2007 Nov; 110(10):3526-31. PubMed ID: 17698634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combination therapy with low-dose cyclosporin A, azathiopurine, and prednisolone for a child with refractory chronic idiopathic thrombocytopenic purpura].
    Matsubara K; Nigami H; Harigaya H; Tanaka T; Yura K; Nozaki H; Iwata A; Fukaya T
    Rinsho Ketsueki; 2007 Mar; 48(3):235-9. PubMed ID: 17441482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trial protocol: a multicentre randomised trial of first-line treatment pathways for newly diagnosed immune thrombocytopenia: standard steroid treatment versus combined steroid and mycophenolate. The FLIGHT trial.
    Pell J; Greenwood R; Ingram J; Wale K; Thomas I; Kandiyali R; Mumford A; Dick A; Bagot C; Cooper N; Hill Q; Bradbury CA
    BMJ Open; 2018 Oct; 8(10):e024427. PubMed ID: 30341143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.